3D printing of silk fibroin-based hybrid scaffold treated with platelet rich plasma for bone tissue engineering
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
3D printing/bioprinting are promising techniques to fabricate scaffolds with well controlled and patient-specific structures and architectures for bone tissue engineering. In this study, we developed a composite bioink consisting of silk fibroin (SF), gelatin (GEL), hyaluronic acid (HA), and tricalcium phosphate (TCP) and 3D bioprinted the silk fibroin-based hybrid scaffolds. The 3D bioprinted scaffolds with dual crosslinking were further treated with human platelet-rich plasma (PRP) to generate PRP coated scaffolds. Live/Dead and MTT assays demonstrated that PRP treatment could obviously promote the cell growth and proliferation of human adipose derived mesenchymal stem cells (HADMSC). In addition, the treatment of PRP did not significantly affect alkaline phosphatase (ALP) activity and expression, but significantly upregulated the gene expression levels of late osteogenic markers. This study demonstrated that the 3D printing of silk fibroin-based hybrid scaffolds, in combination with PRP post-treatment, might be a more efficient strategy to promote osteogenic differentiation of adult stem cells and has significant potential to be used for bone tissue engineering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Markstedt, K., Mantas, A., Tournier, I., Martínez Ávila, H., Hägg, D., & Gatenholm, P. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00188 · Cited by 1,528
Murray, M. M., Spindler, K. P., Abreu, E., Muller, J. A., Nedder, A., Kelly, M., Frino, J., Zurakowski, D., Valenza, M., Snyder, B. D., et al. (2007) · Journal of Orthopaedic Research · doi:10.1002/jor.20282 · Cited by 321
Cited by
Krishani, M., Shin, W. Y., Suhaimi, H., & Sambudi, N. S. (2023) · Gels · doi:10.3390/gels9020100 · Cited by 328
Niu, Y., Wang, Z., Shi, Y., Dong, L., & Wang, C. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.08.012 · Cited by 213
Hu, H., Zhang, H., Bu, Z., Liu, Z., Lv, F., Pan, M., Huang, X., & Cheng, L. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s389471 · Cited by 69
“Live and dead assay As previously described[35], to evaluate the viability of the scaffolds immobilized sEVs, BMSCs were seeded in the scaffold at a density of 1×104 cells/mL in a 24-well plate for 24 h.”
MethodTan, X. H., Liu, L., Mitryashkin, A., Wang, Y., & Goh, J. C. H. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00313 · Cited by 36
Silk fibroin methacrylation: chemical synthesis to biomechanical optimization in tissue engineering
Wu, C. A., Zhu, Y., & Woo, Y. J. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c01931 · Cited by 17
Metadata
- Authors
- Wei, L., Wu, S., Kuss, M., Jiang, X., Sun, R., Reid, P., Qin, X., & Duan, B.
- Venue
- Bioactive Materials
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 4
- Pages
- 256-260
- ISSN
- 2097-1192 (ISSN-L)
- 2452-199X
- OpenAlex
- W2976470767
- Cited by
- 113
- References
- 2
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 3D printing of silk fibroin-based hybrid scaffold treated with platelet rich plasma for bone tissue engineering. https://app.cochat.ai/papers/10.1016/j.bioactmat.2019.09.001
- The paper
- Wei, L., Wu, S., Kuss, M., Jiang, X., Sun, R., Reid, P., Qin, X., & Duan, B. (2019). 3D printing of silk fibroin-based hybrid scaffold treated with platelet rich plasma for bone tissue engineering. Bioactive Materials. https://doi.org/10.1016/j.bioactmat.2019.09.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.